JNGLX
Price
$66.15
Change
+$0.05 (+0.08%)
Updated
Jul 3 closing price
Net Assets
4.35B
LYFAX
Price
$12.21
Change
-$0.01 (-0.08%)
Updated
Jul 3 closing price
Net Assets
34.45M
Interact to see
Advertisement

JNGLX vs LYFAX

Header iconJNGLX vs LYFAX Comparison
Open Charts JNGLX vs LYFAXBanner chart's image
Janus Henderson Global Life Sciences D
Price$66.15
Change+$0.05 (+0.08%)
VolumeN/A
Net Assets4.35B
AlphaCentric Life Sciences & Hlthcare A
Price$12.21
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets34.45M
JNGLX vs LYFAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LYFAX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a StrongBuy and LYFAX is a StrongSell.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.35B vs. LYFAX (34.5M). LYFAX pays higher dividends than JNGLX: LYFAX (2.05) vs JNGLX (0.36). JNGLX was incepted earlier than LYFAX: JNGLX (27 years) vs LYFAX (6 years). LYFAX (1.91) is less costly to investors than JNGLX (0.80). LYFAX is a more actively managed with annual turnover of: 164.00 vs. JNGLX (35.00). JNGLX (2500) and LYFAX (2500) have matching initial minimum investment requirements. LYFAX annual gain was more profitable for investors over the last year : 5.30 vs. JNGLX (-11.81). LYFAX return over 5 years is better than : 10.42 vs. JNGLX (4.83).
JNGLXLYFAXJNGLX / LYFAX
Total Expense Ratio0.801.6648%
Annual Report Gross Expense Ratio0.801.9142%
Fund Existence27 years6 years-
Gain YTD-2.637-2.474107%
Front LoadN/A6%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.35B34.5M12,609%
Annual Yield % from dividends0.362.0517%
Returns for 1 year-11.815.30-223%
Returns for 3 years9.243.98232%
Returns for 5 years4.8310.4246%
Returns for 10 years10.86N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LEAOX14.010.10
+0.72%
Lazard Emerging Markets Eq Advtg Open
TLVIX31.470.16
+0.51%
Thrivent Large Cap Value S
FNICX32.23N/A
N/A
Fidelity Advisor New Insights C
FANIX48.30N/A
N/A
Fidelity Advisor Energy I
MOJAX15.49N/A
N/A
Donoghue Forlines Momentum A